# Fesoterodine on Urgency Episodes in Parkinson's Disease Population

> **NCT02385500** · PHASE4 · TERMINATED · sponsor: **Sir Mortimer B. Davis - Jewish General Hospital** · enrollment: 5 (actual)

## Conditions studied

- Urinary Bladder, Overactive
- Parkinson Disease

## Interventions

- **DRUG:** Fesoterodine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02385500
- **Lead sponsor:** Sir Mortimer B. Davis - Jewish General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-09
- **Primary completion:** 2019-06-07
- **Final completion:** 2019-06-07
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Insufficient or untimely patient recruitment
- **Last updated:** 2019-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02385500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02385500, "Fesoterodine on Urgency Episodes in Parkinson's Disease Population". Retrieved via AI Analytics 2026-09-10 from https://api.ai-analytics.org/clinical/NCT02385500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*